
Robeauté Secures £23 Million for Development of Microrobots in Neurosurgery
Robeauté raises £23 million for microrobots in neurosurgery. These tiny robots aim to improve brain treatment and monitoring. 🧠🤖
Discover the newest research about AI innovations in 🧪 Drug Discovery.

Robeauté raises £23 million for microrobots in neurosurgery. These tiny robots aim to improve brain treatment and monitoring. 🧠🤖

Health Tech Insights: Expectations for 2025 📊
Anticipation grows for NHS digital health advancements, focusing on data-driven care, integrated systems, and AI innovations. 🏥✨

AI is transforming drug discovery for rare diseases, addressing challenges in treatment options and diagnostics. 🌍💊

Evo is a generative AI model that writes genetic code, aiding research in genomics and bioengineering. 🧬✨

New research highlights innovative methods to discover VEGFR-2 inhibitors using advanced deep learning techniques. 🧬💡

Cholesterol’s unique role in health is explored through innovative in silico tools for predicting protein interactions. 🧬🔍

Ginkgetin from Ginkgo biloba shows promise in reducing inflammation and aging effects by targeting the STING pathway. 🌿✨

Pharmaceutical students value machine learning training for future careers. Integration into curricula is essential for innovation. 📚💡

Discover how VirtuDockDL enhances drug discovery using deep learning. 🧬 It achieves remarkable accuracy in identifying potential drug candidates. 💊

Exploring drug repurposing for neglected diseases can enhance research efficiency and reduce costs. 🌍💊 Read our review of a recent study.